oleanolic acid has been researched along with Leukemia, Myeloid, Acute in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caffarena, ER; Gattass, CR; Hammes, ASO; Maia, RC; Pereira, MXG; Pereira, TH; Pozzo, AR; Vasconcelos, FC | 1 |
| Beermann, C; Fußbroich, D; Schneider, P; Schubert, R; Zielen, S | 1 |
| Delebinski, CI; Eggert, A; Hoff, F; Jäger, S; Kleinsimon, S; Mulsow, K; Rolff, J; Seifert, G; Twardziok, M | 1 |
| Li, M; Murphy, WJ; Redelman, D; Sun, K; Welniak, LA | 1 |
| Ahmad, R; Galinsky, I; Kharbanda, S; Kufe, D; Liu, S; Meyer, C; Nelson, E; Stone, R; Weisberg, E | 1 |
| Andreeff, M; Belmont, J; Estrov, Z; Jackson, CE; Kantarjian, H; Konopleva, M; Lee, RM; McQueen, T; Monaco, G; Munsell, M; Sporn, MB; Tsao, T; Wang, RY | 1 |
| Boe, A; Diverio, D; Foà, R; LoCoco, F; Mariani, G; Peschle, C; Riccioni, R; Riti, V; Senese, M; Sporn, M; Testa, U | 1 |
| Andreeff, M; Chang, S; Estrov, Z; Gribble, G; Harris, D; Honda, T; Jackson, CE; Konopleva, M; Leysath, CE; May, WS; Munsell, M; Ruvolo, P; Sporn, MB; Stiouf, I; Suh, N; Tsao, T; Zhao, S | 1 |
8 other study(ies) available for oleanolic acid and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Antitumor Effect of Pomolic Acid in Acute Myeloid Leukemia Cells Involves Cell Death, Decreased Cell Growth and Topoisomerases Inhibition.
Topics: Antineoplastic Agents; Cell Death; Cell Proliferation; Cell Survival; DNA Cleavage; DNA Topoisomerases; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Models, Molecular; Molecular Conformation; Oleanolic Acid; Structure-Activity Relationship; Topoisomerase Inhibitors; U937 Cells | 2018 |
Impact of soyasaponin I on TLR2 and TLR4 induced inflammation in the MUTZ-3-cell model.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; B7-2 Antigen; Cell Line, Tumor; Cell Proliferation; Cell Shape; Chemokines; Cytokines; Endotoxins; Humans; Immunologic Factors; Leukemia, Myeloid, Acute; Monocytes; Neoplasm Proteins; Oleanolic Acid; Osmolar Concentration; Saponins; Toll-Like Receptor 2; Toll-Like Receptor 4 | 2015 |
A Natural Combination Extract of Viscum album L. Containing Both Triterpene Acids and Lectins Is Highly Effective against AML In Vivo.
Topics: Adolescent; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Child; Dose-Response Relationship, Drug; Female; HL-60 Cells; Humans; Interleukin Receptor Common gamma Subunit; Leukemia, Myeloid, Acute; Male; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Oleanolic Acid; Plant Extracts; Plant Lectins; Triterpenes; Tumor Burden; Tumor Cells, Cultured; U937 Cells; Viscum album; Xenograft Model Antitumor Assays | 2015 |
The triterpenoid CDDO-Me delays murine acute graft-versus-host disease with the preservation of graft-versus-tumor effects after allogeneic bone marrow transplantation.
Topics: Animals; Apoptosis; Bone Marrow Transplantation; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colon; Female; Graft vs Host Disease; Graft vs Tumor Effect; Immunosuppressive Agents; Integrins; Leukemia, Myeloid, Acute; Liver; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Oleanolic Acid; Spleen; Survival Analysis; T-Lymphocytes; Transplantation, Homologous; Tumor Necrosis Factor-alpha | 2010 |
Combining the FLT3 inhibitor PKC412 and the triterpenoid CDDO-Me synergistically induces apoptosis in acute myeloid leukemia with the internal tandem duplication mutation.
Topics: Aged; Aged, 80 and over; Animals; Apoptosis; Caspase 3; Cell Growth Processes; Cell Survival; Drug Synergism; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Male; Mice; Mutation; Oleanolic Acid; Phosphorylation; Signal Transduction; Staurosporine | 2010 |
The synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces caspase-dependent and -independent apoptosis in acute myelogenous leukemia.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Inducing Factor; Caspases; Cell Division; Cell Line; Flavoproteins; Humans; Leukemia, Myeloid, Acute; Membrane Potentials; Membrane Proteins; Mitochondria; Oleanolic Acid; Phosphatidylserines; PPAR gamma; Proto-Oncogene Proteins c-bcl-2 | 2004 |
Resistance of acute myeloid leukemic cells to the triterpenoid CDDO-Imidazolide is associated with low caspase-8 and FADD levels.
Topics: Apoptosis; Caspase 8; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Activation; Fas-Associated Death Domain Protein; Humans; Imidazoles; Leukemia, Myeloid, Acute; Oleanolic Acid; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured | 2008 |
Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia.
Topics: Annexin A5; Apoptosis; bcl-2-Associated X Protein; Blast Crisis; Caspase 3; Caspases; Cell Differentiation; Cell Survival; Cytarabine; DNA Fragmentation; Drug Interactions; Flow Cytometry; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Membrane Potentials; Mitogen-Activated Protein Kinases; Oleanolic Acid; Phosphorylation; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Retinoids; Tretinoin; Tumor Cells, Cultured | 2002 |